Skip to main content
. 2019 Feb 7;6(1):ENEURO.0390-18.2019. doi: 10.1523/ENEURO.0390-18.2019

Table 1.

Summary of all injections

Strain n Injected with Injection site Injection amount Figure
C57BL/6J 4 (3 M, 1 F) Retrobeads OB (dispersed between 2400 and 800 μm ventral) 900 nl 2A–C, 3
C57BL/6J 2 M Retrobeads OB 200 nl 2A–C, 3
C57BL/6J 7 M AAVretro-GFP OB 200 nl 2D, 4A–G
C57BL/6J 2 M AAVretro-GFP OT 500 nl 4H
Ai9 6 M AAVretro-Cre OB 200 nl 2E, 5A–G
Ai9 1 M, 1 F AAVretro-Cre OT 500 nl 5H
Ai9 1 M, 2 sF AAVretro-Cre OB (1, 1.5, and 2 mm anterior the rhinal sinus, 1 mm lateral, 1.5 mm ventral) 200 nl × 3 sites = 600 nl total 6

Unless otherwise noted, OB injections were given at 1.5 mm anterior the rhinal sinus, 1 mm lateral, and 1.5 mm ventral, and OT injections were given at 1.5 mm anterior bregma, 1.2 mm lateral, and 4.8 mm ventral.